Friday, December 19, 2014

Today's Datapoint


$250 billion in savings could be realized over the next 10 years if the FDA approves biosimilar versions of 11 selected biologics, according to Express Scripts Holding Co.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)